Microsatellite instability among individuals of Hispanic origin with colorectal cancer

Cancer

Volumn 116, Issue 21, 2010, Pages 4965-4972

  Gupta, Samir ^a,b,c   Ashfaq, Raheela ^d   Kapur, Payal ^a   Afonso, Bianca B ^e   Nguyen, Thuy Phuong T ^f,g   Ansari, Faryal ^a   Boland, C Richard ^f,g   Goel, Ajay ^f,g   Rockey, Don C ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b PARKLAND HEALTH AND HOSPITAL SYSTEM   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d CARIS LIFE SCIENCES   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^g BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Colorectal neoplasms; DNA mismatch repair; Genomic instability; Hispanic Americans; Microsatellite instability

Indexed keywords

BAT25 PROTEIN; BAT26 PROTEIN; NR21 PROTEIN; NR24 PROTEIN; NR27 PROTEIN; PROTEIN; PROTEIN MLH1; PROTEIN MSH6; PROTEIN MUTS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PATIENT; CANCER REGISTRY; COLORECTAL CANCER; ETHNICITY; FEMALE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HISPANIC; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RACE; RETROSPECTIVE STUDY; SURVIVAL TIME;

COLORECTAL NEOPLASMS; DNA MISMATCH REPAIR; FEMALE; HISPANIC AMERICANS; HUMANS; MICROSATELLITE INSTABILITY; MIDDLE AGED; UNITED STATES;

EID: 78249250888     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25486     Document Type: Article

References (29)

1. Samowitz WS, Curtin K, Ma KN, et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev. 2001; 10: 917 -923.
2. Satia JA, Keku T, Galanko JA, et al. Diet, lifestyle, and genomic instability in the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev. 2005; 14: 429 -436.
3. Percesepe A, Borghi F, Menigatti M, et al. Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study. J Clin Oncol. 2001; 19: 3944 -3950.
4. Slattery ML, Curtin K, Anderson K, et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst. 2000; 92: 1831 -1836.
5. Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003; 349: 247 -257.
6. Popat S, Hubner R, Houlston RS,. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol. 2005; 23: 609 -618.
7. Bertagnolli MM, Niedzwiecki D, Compton CC, et al. Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803. J Clin Oncol. 2009; 27: 1814 -1821.
8. Pohl A, Lenz HJ,. Individualization of therapy for colorectal cancer based on clinical and molecular parameters. Gastrointest Cancer Res. 2008; 2: S38 -S41.
9. Ashktorab H, Smoot DT, Carethers JM, et al. High incidence of microsatellite instability in colorectal cancer from African Americans. Clin Cancer Res. 2003; 9: 1112 -1117.
10. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010; 116: 544 -573.
11. American Cancer Society. Cancer Facts & Figures for Hispanics/Latinos 2006-2008. Atlanta, GA: American Cancer Society; 2008.
12. Jenkins MA, Hayashi S, O'Shea AM, et al. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology. 2007; 133: 48 -56.
13. Suraweera N, Duval A, Reperant M, et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology. 2002; 123: 1804 -1811.
14. De Jesus-Monge WE, Gonzalez-Keelan C, Zhao R, Hamilton SR, Rodriguez-Bigas M, Cruz-Correa M,. Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico. Fam Cancer. 2010; 9: 155 -166.
15. Balmana J, Balaguer F, Castellvi-Bel S, et al. Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients. J Med Genet. 2008; 45: 557 -563.
16. Pinol V, Castells A, Andreu M, et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA. 2005; 293: 1986 -1994.
17. Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005; 352: 1851 -1860.
18. Poynter JN, Siegmund KD, Weisenberger DJ, et al. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev. 2008; 17: 3208 -3215.
19. Lynch HT, Lynch PM,. Molecular screening for the Lynch syndrome-better than family history? N Engl J Med. 2005; 352: 1920 -1922.
20. Byfield SA, Syngal S,. Clinical guidelines versus universal molecular testing: are we ready to choose an optimal strategy for Lynch syndrome identification? Am J Gastroenterol. 2008; 103: 2837 -2840.
21. Lindor NM, Petersen GM, Hadley DW, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA. 2006; 296: 1507 -1517.
22. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer statistics, 2009. CA Cancer J Clin. 2009; 59: 225 -249.
23. Diergaarde B, Braam H, van Muijen GN, Ligtenberg MJ, Kok FJ, Kampman E,. Dietary factors and microsatellite instability in sporadic colon carcinomas. Cancer Epidemiol Biomarkers Prev. 2003; 12: 1130 -1136.
24. Poynter JN, Haile RW, Siegmund KD, et al. Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status. Cancer Epidemiol Biomarkers Prev. 2009; 18: 2745 -2750.
25. Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults-United States, 2007. MMWR Morb Mortal Wkly Rep. 2008; 57: 1221 -1226.
26. King DE, Mainous AG 3rd, Carnemolla M, Everett CJ,. Adherence to healthy lifestyle habits in US adults, 1988-2006. Am J Med. 2009; 122: 528 -534.
27. Monroe KR, Hankin JH, Pike MC, et al. Correlation of dietary intake and colorectal cancer incidence among Mexican-American migrants: the multiethnic cohort study. Nutr Cancer. 2003; 45: 133 -147.
28. Center MM, Jemal A, Ward E,. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev. 2009; 18: 1688 -1694.
29. Hao Y, Jemal A, Zhang X, Ward EM,. Trends in colorectal cancer incidence rates by age, race/ethnicity, and indices of access to medical care, 1995-2004 (United States). Cancer Causes Control. 2009 Jun 19. [Epub ahead of print].